The latest price target for Sernova Biotherapeutics (OTCQB:SEOVF) was reported by Raymond James on April 4, 2024. The analyst firm set a price target for $1.50 expecting SEOVF to rise to within 12 months (a possible 956.71% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Sernova Biotherapeutics (OTCQB:SEOVF) was provided by Raymond James, and Sernova Biotherapeutics initiated their market perform rating.

There is no last upgrade for Sernova Biotherapeutics

There is no last downgrade for Sernova Biotherapeutics.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sernova Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sernova Biotherapeutics was filed on April 4, 2024 so you should expect the next rating to be made available sometime around April 4, 2025.

While ratings are subjective and will change, the latest Sernova Biotherapeutics (SEOVF) rating was a initiated with a price target of $0.00 to $1.50. The current price Sernova Biotherapeutics (SEOVF) is trading at is $0.14, which is within the analyst’s predicted range.